Navigation Links
Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio
Date:10/29/2009

NEWPORT, Ky., Oct. 29 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today the completion of $50 million in equity financing. The round was led by Longitude Capital with participation from new investors Skandia and Silver Point Capital. Other current investors that participated in the financing include MPM Capital, LLC, AIG Investments' sponsored funds, Perseus-Soros Biopharmaceutical Fund, Blue Chip Venture Company, HealthCare Ventures, LLC, and Union Springs, LLC. Aquilo Partners, L.P., a life science investment bank, acted as the exclusive placement agent for the financing.

Michael J. Valentino, President and CEO commented, "I am extremely pleased to have secured additional financial resources which will be used to support our ongoing development and commercialization strategy for our emerging product portfolio."

In June 2009, Xanodyne received Food and Drug Administration (FDA) approval for Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules, a new treatment option for relief of mild to moderate acute pain in adults (18 years of age or older). Zipsor was launched nationally to physicians and patients in September.

In addition, the company expects FDA action soon on Lysteda(TM) (formerly XP12B), an oral tranexamic acid product under priority review. If approved, Lysteda would be the first and only oral therapeutic agent indicated specifically for the treatment of women suffering from cyclic heavy menstrual bleeding.

Valentino added, "The continued commitment from our investor groups allows us to remain focused on aggressively executing our product commercialization plans and optimizing the other assets in our portfolio."

About Xanodyne

Xanodyne Pharmaceuticals, Inc., which commenced operations in 2001, is an integra
'/>"/>

SOURCE Xanodyne Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Globus Medical Raises $110 Million in Series E Financing Round
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
4. Romark Laboratories Raises $18 Million in Institutional Financing
5. Light Sciences Oncology Raises $40.1 Million in Series C Financing
6. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
7. ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
8. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
9. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
10. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
11. SynergEyes, Inc. Raises $13.3 Million in Series C Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the ...
(Date:5/17/2013)... , May 17, 2013 Medical devices are ... a biological product. In light of their different mechanisms, ... are much more complicated than drug trails due to ... MD safety instead of evaluating both safety and efficacy ... FDA (which is the same as the SFDA) evaluate ...
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, ... its Fast-Track Advanced Technology Small Business Technology Transfer ... of Allergy and Infectious Diseases (NIAID), a division ... the development of novel human antibody therapeutics to ... or Staph) infections, including methicillin-resistant S. ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4
(Date:5/18/2013)... During Better Hearing and Speech Month, ... legal protections they have, including the right to bring ... child’s treatment or hearing aid device, attorney Ronald E. ... Speech-Language-Hearing Association has used the month of May to ... such as cochlear implants, which can improve the quality ...
(Date:5/18/2013)... 6Webs.com is the leader in home ... comprehensive comparisons make 6Webs.com the useful resource consumers prefer ... recently finished conducting their assessments of the leading wireless ... 6Webs.com reports, "There has been an increase interest in ... use, expandability and mobility. Combine these features with the ...
(Date:5/18/2013)... The California College of Ayurveda Spa is ... Ayurvedic Spa , the client receives stress relief therapies ... lifestyle recommendations and stress management techniques by a Clinical ... traditional healthcare system of India. It is based on ... basis for all optimum health. Ayurveda believes that where ...
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in dental ... knowledge of the root causes of sleep apnea to provide ... Better Sleep Month, Dr. Tracey points out estimates revealing that ... and sleep apnea is one of the most common of ... stop breathing at different times while sleeping. When this happens, ...
(Date:5/18/2013)... 18, 2013 John Ravera, D.D.S., a ... of a new member to his dental team, Courtney Marino. ... the field for over 10 years. She received her degree ... was elected a member of Sigma Pi Alpha, a national ... enjoys working with patients of all ages, helping them understand ...
Breaking Medicine News(10 mins):Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2
... Kural village in Orissa's Nayagarh district after four persons died ... health official told Sunday. ,The dead ... and Ghanashyam Panda. They were among the 642 persons affected ... Bhubaneswar. ,The village is the biggest in Nayagarh ...
... alcohol treatment studies are designed in ways that inadvertently ... School of Medicine researcher who led the effort ... study eligibility criteria can have unintended, negative consequences. ... 100,000 alcohol treatment patients, Keith Humphreys, PhD, professor of ...
... papers selected for publication in the August 2007 issue ... that become pregnant before they have achieved their full ... nourishment for their fetuses to develop without physical deficits. ... managing pregnancies of adolescent human females, who, in increasing ...
... in prostate specific antigen (PSA) levels is the most significant ... new study published in the journal Cancer. ... to treatment (PSA Velocity) is more than 2 ng/ml/year, it ... prostate cancer. ,According to the researchers, the new ...
... Wannabe porn star 'Katee Holmes', the namesake of Hollywood actress ... by losing her virginity on film. ,The ... she will lose her virginity in 26 days 15 hours ... threatening legal action after the teenage aspiring porn star. Katie ...
... new study published in The Journal of Sexual Medicine examines ... cause them, in pre- and post-menopausal women . Participants in ... their own feelings of sexual desire and those who felt ... assessment tool was used for empirically categorizing stimuli associated with ...
Cached Medicine News:Health News:Limiting Eligibility for Medical Studies can Omit Women and African-Americans 2Health News:Limiting Eligibility for Medical Studies can Omit Women and African-Americans 3Health News:Sheep Offer Model for Undernourishment in Pregnant Teen Girls 2Health News:Scientists Identify the Most Significant Single Predictor of Aggressive Prostate Cancer 2Health News:Pre- and Post-menopausal Women Responses Equally to Most Sexual Desire Cues 2
... This therapeutic system ... the patient in mind. ... surgery and ongoing therapy, ... low-risk and effective therapy. ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
... only one of the most modern lithotripters available ... from being designed for the treatment of the ... the MODULITH SLX can also be employed for ... equally suitable for the treatment of gallstones or ...
... The MINILITH SL1 developed by STORZ ... of extensive experience in the field of ... of the specific requirements to be met ... therapy, as has been outlined above. The ...
Medicine Products: